The Creation of Psychopharmacology
نویسنده
چکیده
Psychiatrists and historians owe a debt to David Healy. Over the years he has conducted interviews with all the leading figures in psychopharmacology. The resultant three volumes of The Psychopharmacologists (Healy, 1996, 1998, 2000) captured a crucial period in the history of psychiatry. Drawing on these interviews and his wide reading of the scholarly literature, Healy has now constructed a subtle and compelling narrative of the development of psychotropic drugs, in particular of chlorpromazine, whose discovery he hails as as important as that of penicillin. This is not a narrow, internalist account of events. Rather, Healy ambitiously relates the emergence of drugs to the wider culture and shows how the two have interacted. He begins with the new science of the Enlightenment; looks at the changing clientele of 19th-century asylums; examines the counterculture’s advocacy of LSD (acid) in the 1960s; charts the growth of the mighty drug companies of today; and, finally, considers what biomedical advances hold for the future of humanity. En route, he boldly challenges received readings of the past and the accepted wisdom about psychiatric drugs. For example, he demonstrates that lithium was first prescribed in the 19th century and that the pre-neuroleptic era, far from representing some kind of ‘dark age’, witnessed the development of several effective treatments. With regard to recent times, Healy judges that the evidence that the selective serotonin reuptake inhibitors (the SSRIs) and the ‘atypical’ antipsychotics are superior to older drugs is weak. Healy asks how we arrived at our present position. It is a position, he suggests, where biological explanations of mental disorder and, indeed, of an increasing proportion of human behaviour are now in the ascendancy; where powerful drug corporations shape how we perceive and classify emotional distress; and where the ‘psychopharmaceutical complex’ ensures that the only therapy considered is medication. For Healy, the key lies with the discovery of chlorpromazine. The advent of this drug in the 1950s saw many patients ‘awake’ from their psychoses and leave the asylum. Thus was community psychiatry born: as a result, clinicians began to see an increasing number of patients with nonpsychotic disorders. In North America, the therapeutic triumph of chlorpromazine dealt a deathblow to psychoanalysis, and medication became the treatment of choice not only for severe mental illness, but for all types of psychic distress. Psychiatry underlined its commitment to a biomedical perspective with the publication of DSM– III in 1980. In tandem, drug companies created markets for their products rather than creating medication in response to the needs of patients. Healy maintains that we are becoming less rather than more rational in our development of new treatments. Science does not evolve progressively in response to carefully conducted research; instead, serendipity plays a major role, leaving scientists to construct a post hoc theory to accommodate the new data. Healy places his treatise in a wider philosophical framework. He contends that our views about the nature of humans have changed dramatically and that a ‘new biomedical self’ is being born. He follows its conception during the time of the Enlightenment, when God was dethroned and La Mettrie postulated that man is a machine, to its birth in the present day when, in the eyes of many, the neurosciences and the Human Genome Project are demonstrating that notions of spirituality and free will are redundant and that human beings can be understood entirely in terms of their biology. Since the Enlightenment, there have been many voices objecting to such a materialist view of man. From Thomas Reid in the 18th century; through Søren Kierkegaard and William James, to Francis Fukuyama in the present day, powerful arguments have been raised in opposition. Perhaps Healy does not give sufficient space to these dissenting voices. However, he has written a highly stimulating and original book, which is brimful of ideas and deserves to be read and debated throughout the psychiatric community and beyond.
منابع مشابه
Listening to the past: history, psychiatry, and anxiety.
This article explores the history of psychiatry and the rise of biological psychiatry and suggests ways in which the study of history can shed light on current psychiatric practice and debate. Focusing on anxiolytics (meprobomate in the 1950s and benzodiazepines in the 1960s, 1970s, and 1980s) as a case study in the development of psychopharmacology, it shows how social and political factors co...
متن کاملCreativity in psychopharmacotherapy - the bright side of face of psychiatric god Janus.
This paper discusses about challenges to psychopharmacotherapy, evidence-based psychopharmacology, creative psychopharmacology, creativity and dopamine, creative-rational polypharmacy as a paradigm for creativity in psychopharmacotherapy, and about polypharmacy classification as a good, bad and ugly By stimulating the patient to participate in the creative and artistic process we effect on his ...
متن کاملThe creation of psychopharmacology
addicts emerging not from the traditional milieu changes. As pharmaceutical companies gained of the urban underclass but from the white control over research and the subsequent suburban middle-classes, and from the 1980s marketing of drug therapies, the faith in science with the disastrous spread of HIV/AIDS, gave increasingly meant a faith in pharmaceutical impetus to new non-medical movements...
متن کاملBrief examination of psychopharmacology
Abimbola Farinde Address for correspondence: Dr. Abimbola Farinde, 500 Medical Center blvd, Webster, Texas, USA. E-mail: [email protected] Since the 1970s, psychiatry has experienced a transformation with regards to available treatment options which have led to the creation of practitioners who are well-trained and versed in psychopharmacology.[1] Each new year brings the opportunity for ...
متن کاملPanic and hypertension: brothers in arms through 5-HT?
S. J. Davies Psychopharmacology Unit, University of Bristol, Bristol, UK. C. A. Lowry Department of Integrative Physiology, University of Colorado, USA. D. J. Nutt Psychopharmacology Unit, University of Bristol, Bristol, UK. Journal of Psychopharmacology 21(6) (2007) 563–566 © 2007 British Association for Psychopharmacology ISSN 0269-8811 SAGE Publications Los Angeles, London, New Delhi and Sin...
متن کامل